tiprankstipranks
3 Best Stocks to Buy Now, 11/14/2024, According to Top Analysts 
PremiumMarket News3 Best Stocks to Buy Now, 11/14/2024, According to Top Analysts 
3M ago
Taysha Gene Therapies Advances in Rett Syndrome Trials
Premium
Company Announcements
Taysha Gene Therapies Advances in Rett Syndrome Trials
3M ago
Taysha Gene Therapies reports Q3 EPS (10c), consensus (9c)
Premium
The Fly
Taysha Gene Therapies reports Q3 EPS (10c), consensus (9c)
3M ago
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
PremiumThe FlyTaysha Gene Therapies announces inducement grant under Nasdaq listing rule
6M ago
Taysha Gene Therapies price target lowered to $6 from $7 at Canaccord
Premium
The Fly
Taysha Gene Therapies price target lowered to $6 from $7 at Canaccord
6M ago
Taysha Gene Therapies reports  Q2 revenue $1.112M, consensus $2.66M
Premium
The Fly
Taysha Gene Therapies reports Q2 revenue $1.112M, consensus $2.66M
6M ago
Taysha Gene Therapies initiated with an Outperform at BMO Capital
PremiumThe FlyTaysha Gene Therapies initiated with an Outperform at BMO Capital
8M ago
Taysha Gene Therapies 14.361M share Spot Secondary priced at $2.25
Premium
The Fly
Taysha Gene Therapies 14.361M share Spot Secondary priced at $2.25
8M ago
Taysha Gene Therapies 14.36M share secondary offering priced at $2.25
Premium
The Fly
Taysha Gene Therapies 14.36M share secondary offering priced at $2.25
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100